Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
NRG Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University Health Network, Toronto
Shanghai Miracogen Inc.
Baylor College of Medicine
Novartis
Sun Yat-sen University
Novartis